| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72162-2100-1 | 72162-2100 | HUMAN PRESCRIPTION DRUG | Clorazepate Dipotassium | Clorazepate Dipotassium | TABLET | ORAL | 20220922 | N/A | ANDA | ANDA215566 | Bryant Ranch Prepack | CLORAZEPATE DIPOTASSIUM | 15 mg/1 | 100 TABLET in 1 BOTTLE (72162-2100-1) |
| 60505-4756-1 | 60505-4756 | HUMAN PRESCRIPTION DRUG | Clorazepate Dipotassium | Clorazepate Dipotassium | TABLET | ORAL | 20220922 | N/A | ANDA | ANDA215566 | Apotex Corp. | CLORAZEPATE DIPOTASSIUM | 15 mg/mg | 100 mg in 1 BOTTLE (60505-4756-1) |
| 60505-4755-1 | 60505-4755 | HUMAN PRESCRIPTION DRUG | Clorazepate Dipotassium | Clorazepate Dipotassium | TABLET | ORAL | 20220922 | N/A | ANDA | ANDA215566 | Apotex Corp. | CLORAZEPATE DIPOTASSIUM | 7.5 mg/mg | 100 mg in 1 BOTTLE (60505-4755-1) |
| 60505-4754-1 | 60505-4754 | HUMAN PRESCRIPTION DRUG | Clorazepate Dipotassium | Clorazepate Dipotassium | TABLET | ORAL | 20220922 | N/A | ANDA | ANDA215566 | Apotex Corp. | CLORAZEPATE DIPOTASSIUM | 3.75 mg/mg | 100 mg in 1 BOTTLE (60505-4754-1) |